Citius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,493 | $1,667 | $3,944 | $0 |
Gross Profit | -718 | -381 | 2,581 | -62 |
EBITDA | -9,970 | -30,433 | -8,445 | -8,321 |
EBIT | -11,732 | -32,194 | -9,019 | -8,383 |
Net Income | -8,862 | -21,231 | -8,220 | -7,959 |
Net Change In Cash | 1,493 | 1,667 | 3,944 | 0 |
Free Cash Flow | -8,677 | -1,300 | -13,008 | -11,880 |
Cash | 17,007 | 4,590 | 7,721 | 4,252 |
Basic Shares | 26,169 | 22,376 | 21,495 | 18,067 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -214 | -209 | -194 | -179 |
EBITDA | -38,201 | -38,640 | -36,537 | -33,136 |
EBIT | -38,415 | -38,849 | -36,732 | -33,316 |
Net Income | -37,433 | -39,138 | -32,542 | -33,640 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -28,361 | |||
Free Cash Flow | -26,552 | -28,201 | -29,060 | -28,361 |
Cash | 4,252 | 3,251 | 26,480 | 41,711 |
Basic Shares | 11,065 | 11,590 | 6,051 | 5,843 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.34 |
2026-03-31 | -$0.95 |
2025-12-31 | -$0.38 |
2025-09-30 | -$0.11 |